Search

Your search keyword '"M. Doubek"' showing total 15 results

Search Constraints

Start Over You searched for: Author "M. Doubek" Remove constraint Author: "M. Doubek" Publication Year Range This year Remove constraint Publication Year Range: This year
15 results on '"M. Doubek"'

Search Results

1. Search for central exclusive production of top quark pairs in proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV with tagged protons

2. Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

3. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

4. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.

5. Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.

6. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study.

7. Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapy.

8. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.

9. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.

10. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

11. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.

12. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.

13. Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.

14. Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions - a case report and a literature review.

15. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.

Catalog

Books, media, physical & digital resources